Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Larry, Goldkind"'
Autor:
Ingvar Bjarnason, Angel Lanas, Andrew Moore, Luis A García-Rodríguez, Byron L Cryer, Lee S. Simon, Larry Goldkind
Publikováno v:
Clinical Gastroenterology and Hepatology. 7:1156-1163
Background & Aims Surrogate endpoints are biomarkers intended to substitute for a clinical endpoint. Are endoscopic ulcers a useful surrogate endpoint for a biological progression to clinical endpoints of ulcer complications (perforation, ulcers, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1bdae879043ee4c6b33edbf385f2c0
https://doi.org/10.1016/j.cgh.2009.03.032
https://doi.org/10.1016/j.cgh.2009.03.032
Autor:
Lee S. Simon, Claire Bombardier, Ken S. Saag, David Henry, Peter Tugwell, Maarten Boers, Larry Goldkind, Andreas Laupacis, Alan J. Silman, Andrew Moore, James F. Fries, Alan Tyndall, Muhammad Mamdani, Randall Stevens, Thomas M. MacDonald, Larry D. Lynd, Gordon H. Guyatt, C. Vibeke Strand, Peter Brooks
Publikováno v:
The Journal of Rheumatology. 36:2114-2121
There is great concern about clearly defining benefit and risk in the context of both drug development and clinical practice. In view of this pressure, the OMERACT Executive identified the need to bring together clinical trialists, pharmacoepidemiolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f1682dc2e6b70ed853981c43473ff1b
https://doi.org/10.3899/jrheum.090591
https://doi.org/10.3899/jrheum.090591
Autor:
Lee S, Simon, C Vibeke, Strand, Maarten, Boers, Peter M, Brooks, Peter S, Tugwell, Claire, Bombardier, James F, Fries, David, Henry, Larry, Goldkind, Gordon, Guyatt, Andreas, Laupacis, Larry, Lynd, Tom, Macdonald, Muhammad, Mamdani, Andrew, Moore, Kenneth G, Saag, Ken S, Saag, Alan J, Silman, Randall, Stevens, Alan, Tyndall
Publikováno v:
The Journal of rheumatology. 36(9)
There is great concern about clearly defining benefit and risk in the context of both drug development and clinical practice. In view of this pressure, the OMERACT Executive identified the need to bring together clinical trialists, pharmacoepidemiolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21013fb703517f138fe693c0d55234fb
https://pubmed.ncbi.nlm.nih.gov/19738223
https://pubmed.ncbi.nlm.nih.gov/19738223